Home›Stock Screener›Biofil Chemicals›Quarterly Results

Biofil Chemicals Quarterly Results

Latest Quarter Net Profit
₹3 Cr
QMarch 2026
Quarterly Results

Biofil Chemicals quarterly results. In 2026, Biofil Chemicals (BIOFILCHEM) reported revenue ₹35 Cr and net profit ₹1 Cr. Check Biofil Chemicals market worth to track the company's total market size over time.

BIOFILCHEM Quarterly Results — Revenue, Profit & EPS Highlights

Biofil Chemicals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Biofil Chemicals screener.

  • Revenue of ₹32 Cr in March 2026 (+0.0% vs March 2026, -5.9% vs March 2025)
  • Net Profit of ₹3 Cr in March 2026 (+0.0% vs March 2026, +200.0% vs March 2025)
  • EBITDA of ₹4 Cr in March 2026 (+0.0% vs March 2026)
  • Operating Margin of 2.0% in March 2026 (+0.0pp vs March 2026)
  • Earnings Per Share of ₹1.71 in March 2026 (+0.0% vs March 2026)

Biofil Chemicals Quarterly Results — Revenue, EBITDA, Net Profit & EPS

BIOFILCHEM quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2026 March 2025 March 2024 March 2023 QoQ YoY
Revenue (₹ Cr) 35 32 34 41 30 9.4% -
Net Profit (₹ Cr) 1 3 1 1 1 - -
EBITDA (₹ Cr) 1 4 1 1 1 - -
EPS (₹) 0.30 1.71 0.34 0.44 0.34 - -
Operating Margin (%) 5.0% 2.0% 3.0% 2.0% 4.0% - -

BIOFILCHEM Share Price Trend — 1-Year Movement Across Quarterly Results

Biofil Chemicals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review BIOFILCHEM P/E comparison to evaluate earnings-based valuation against sector peers.

Profitability Ratios

Profit Margin 9.4%
EBITDA Margin 12.5%
Operating Margin 2.0%
ROE (Annual) 13.6%

Balance Sheet Highlights

Total Assets ₹43 Cr
Total Equity ₹22 Cr
Current Assets ₹ Cr
Current Liabilities ₹1 Cr

Cash Flow Analysis

Operating Cash Flow ₹-1 Cr
Investing Cash Flow ₹1 Cr
Financing Cash Flow ₹3 Cr
Net Cash Flow ₹3 Cr

Current Market Data

Current Price ₹28.86
Exchange NSE
Last Updated Oct 23, 2026

Revenue Trend (₹ Cr)

March 2024 41
March 2025 34
March 2026 32
2026 35

Net Profit Trend (₹ Cr)

March 2024 1
March 2025 1
March 2026 3
2026 1

Operating Margin Trend (%)

March 2024 2.0%
March 2025 3.0%
March 2026 2.0%
2026 5.0%

BIOFILCHEM vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Biofil Chemicals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹421,995.00 Cr 1748.0 15,018 2,710 -5.6% - 18.0% 154.7
Divis Laboratories
Mar 2026 		₹241,231.30 Cr 8950.0 2,986 751 -5.0% - 25.2% 316.1
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4524.4 4,111 364 +27.7% +42.2% 8.9% 393.1
Laurus Labs
Mar 2026 		₹111,790.60 Cr 1970.0 1,823 282 -10.5% - 15.5% 381.0
Zydus Life Science
Mar 2026 		₹111,111.95 Cr 1129.4 7,569 1,341 -4.3% - 17.7% 89.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores